Research Topics
Genomes and Genes | PETER W LIBBYSummaryAffiliation: Harvard University Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Association of thrombospondin-1 and cardiac allograft vasculopathy in human cardiac allograftsX M Zhao
Cardiovascular Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA, USA
Circulation 103:525-31. 2001..In particular, we tested the involvement in cardiac allografts of thrombospondin-1 (TSP-1), a matrix glycoprotein that inhibits angiogenesis and facilitates smooth muscle cell (SMC) proliferation...
The forgotten majority: unfinished business in cardiovascular risk reductionPeter Libby
Donald W Reynolds Cardiovascular Clinical Research Center, Department of Medicine, Brigham and Women s Hospital, and Harvard Medical School, Boston, Massachusetts, USA
J Am Coll Cardiol 46:1225-8. 2005..Thus, physicians must continue to educate their patients regarding an optimal balance of drug therapy and personal behavior...
Inflammatory mechanisms: the molecular basis of inflammation and diseasePeter Libby
Harvard Medical School, Brigham and Women s Hospital, Boston, MA 02115, USA
Nutr Rev 65:S140-6. 2007....
Inflammation in atherosclerosisPeter Libby
Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA
Arterioscler Thromb Vasc Biol 32:2045-51. 2012..Inflammation regulates aspects of plaque biology that trigger the thrombotic complications of atherosclerosis. Translation of these discoveries to humans has enabled both novel mechanistic insights and practical clinical advances...
Molecular imaging of atherosclerosis for improving diagnostic and therapeutic developmentThibaut Quillard
Division of Cardiovascular Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Circ Res 111:231-44. 2012....
The serpin proteinase inhibitor 9 is an endogenous inhibitor of interleukin 1beta-converting enzyme (caspase-1) activity in human vascular smooth muscle cellsJ L Young
Cardiovascular Medicine, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
J Exp Med 191:1535-44. 2000....
Inflammation and cardiovascular disease mechanismsPeter Libby
Harvard Medical School and Brigham and Women s Hospital, Boston, MA 02115, USA
Am J Clin Nutr 83:456S-460S. 2006....
Pathophysiology of coronary artery diseasePeter Libby
Donald W Reynolds Cardiovascular Clinical Research Center, Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass 02115, USA
Circulation 111:3481-8. 2005..The concept of "interventional cardiology" must expand beyond mechanical revascularization to embrace preventive interventions that forestall future events...
Changing concepts of atherogenesisP Libby
Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts, USA
J Intern Med 247:349-58. 2000..Such new treatments could further reduce the considerable burden of morbidity and mortality due to this modern scourge, and reduce reliance on costly technologies that address the symptoms rather than the cause of atherosclerosis...
Metformin and vascular protection: a cardiologist's viewP Libby
Leducq Center for Cardiovascular Research, Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Diabetes Metab 29:6S117-20. 2003..The potential vascular protective effects of metformin, demonstrated by the UK Prospective Diabetes Study, may complement other strategies within such a framework...
Vascular biology of atherosclerosis: overview and state of the artPeter Libby
Leducq Center for Cardiovascular Research, Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
Am J Cardiol 91:3A-6A. 2003..Thus, the time has come to embrace inflammation as a common pathway for atherogenic risk factors and for providing new opportunities for therapeutic intervention...
Inflammation in atherosclerosisPeter Libby
Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
Nature 420:868-74. 2002..Identifying the triggers for inflammation and unravelling the details of inflammatory pathways may eventually furnish new therapeutic targets...
Stabilization of atherosclerotic plaques: new mechanisms and clinical targetsPeter Libby
Leducq Center for Cardiovascular Research, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA
Nat Med 8:1257-62. 2002
Inflammation and atherosclerosisPeter Libby
Leducq Center for Cardiovascular Research, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Circulation 105:1135-43. 2002....
Managing the risk of atherosclerosis: the role of high-density lipoproteinP Libby
Cardiovascular Division of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
Am J Cardiol 88:3N-8N. 2001..This article examines recent experimental approaches aimed at elucidating these antiatherogenic, HDL-mediated mechanisms...
Plaque stabilization: Can we turn theory into evidence?Peter Libby
Division of Cardiovascular Medicine, Brigham and Women s Hospital, Boston, Massachusetts 02135, USA
Am J Cardiol 98:26P-33P. 2006..This article reviews the evolution of the concept of plaque stabilization and reexamines the evidence for the role of statins in that process...
Atherosclerosis: disease biology affecting the coronary vasculaturePeter Libby
Harvard Medical School and Cardiovascular Division, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
Am J Cardiol 98:3Q-9Q. 2006..Treatment of vulnerable patients should include measures to stabilize plaques and to lessen the thrombotic consequences of plaque disruptions...
Progress and challenges in translating the biology of atherosclerosisPeter Libby
Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, Massachusetts 02115, USA
Nature 473:317-25. 2011..Understanding how to combine experimental and clinical science will provide further insight into atherosclerosis and could lead to new clinical applications...
The vascular biology of atherosclerosis and imaging targetsPeter Libby
Donald W Reynolds Cardiovascular Clinical Research Center, Harvard Medical School, Boston, Massachusetts, USA
J Nucl Med 51:33S-37S. 2010..The goals for the years to come must include translation of the experimental work to visualization of these appealing biologic targets in humans...
Clinical implications of inflammation for cardiovascular primary preventionPeter Libby
Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
Eur Heart J 31:777-83. 2010..The clinical use of biomarkers of inflammation may provide the practitioner with a tool to help gauge residual risk, and chart a course for its optimal management...
Inflammation in atherosclerosis: transition from theory to practicePeter Libby
Division of Cardiovascular Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Circ J 74:213-20. 2010..Inflammation is thus moving from a theoretical concept to a tool that provides practical clinical utility in risk assessment and targeting of therapy...
Molecular and cellular mechanisms of the thrombotic complications of atherosclerosisPeter Libby
Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
J Lipid Res 50:S352-7. 2009..This convergence of clinical and pathological observations highlighted the importance of understanding the mechanisms of disruption of plaques that can precipitate thromboses...
Role of inflammation in atherosclerosis associated with rheumatoid arthritisPeter Libby
Harvard Medical School and Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
Am J Med 121:S21-31. 2008....
Inflammation in atherosclerosis: from pathophysiology to practicePeter Libby
Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, Massachusetts 02115, USA
J Am Coll Cardiol 54:2129-38. 2009..This review provides an update of the role of inflammation in atherogenesis and highlights how translation of these advances in basic science promises to change clinical practice...
Inflammation in diabetes mellitus: role of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma agonistsPeter Libby
Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
Am J Cardiol 99:27B-40B. 2007....
The molecular mechanisms of the thrombotic complications of atherosclerosisP Libby
Division of Cardiovascular Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
J Intern Med 263:517-27. 2008..Novel molecular imaging strategies may permit visualization of proteinase activity in vivo, providing a new functional window on pathophysiology...
Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosisK Shimizu
Departments ofMedicine and Pathology, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
J Immunol 165:3506-18. 2000..Therefore, we propose that early alloresponses, without CD40-CD40L costimulation, induce allospecific tolerance but may trigger allo-independent mechanisms that ultimately result in graft vasculopathy...
Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient miceL Gu
Department of Adult Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
Mol Cell 2:275-81. 1998..Thus, MCP-1 plays a unique and crucial role in the initiation of atherosclerosis and may provide a new therapeutic target in this disorder...
Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbitsY Fukumoto
Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA
Circulation 103:993-9. 2001..CONCLUSIONS: This study showed that statins can reduce MMP expression in atheroma and that cell-permeant statins can decrease SMC number and collagen gene expression in vivo...
CD40 signaling and plaque instabilityU Schonbeck
Leducq Center for Cardiovascular Research, Cardiovascular Medicine, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
Circ Res 89:1092-103. 2001....
Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma: a novel collagenolytic pathway suggested by transcriptional profilingM P Herman
Leducq Center for Cardiovascular Research, Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA
Circulation 104:1899-904. 2001..CONCLUSIONS: These data point to MMP-8 as a previously unsuspected participant in collagen breakdown, an important determinant of the vulnerability of human atheroma...
Biomechanical strain induces class a scavenger receptor expression in human monocyte/macrophages and THP-1 cells: a potential mechanism of increased atherosclerosis in hypertensionH Sakamoto
Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA
Circulation 104:109-14. 2001..7+/-4.7% for animals on standard chow; P<0.001). CONCLUSIONS: Biomechanical strain induces SRA expression by monocyte/macrophages, suggesting a novel mechanism for promotion of atherosclerosis in hypertensive patients...
Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosisF Mach
Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Proc Natl Acad Sci U S A 94:1931-6. 1997....
Hyperlipidemia and atherosclerotic lesion development in LDL receptor-deficient mice fed defined semipurified diets with and without cholateA H Lichtman
Vascular Research Division, Department of Pathology, Brigham and Women s Hospital, Boston, MA 02115, USA
Arterioscler Thromb Vasc Biol 19:1938-44. 1999..This study shows that sodium cholate is not necessary for the formation of atherosclerosis in LDLR(-/-) mice and that precisely defined semipurified diets are a valuable tool for the examination of diet-gene interactions...
Reduction of atherosclerosis in mice by inhibition of CD40 signallingF Mach
Vascular Medicine and Atherosclerosis Unit, Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
Nature 394:200-3. 1998..These data support the involvement of inflammatory pathways in atherosclerosis and indicate a role for CD40 signalling during atherogenesis in hyperlipidaemic mice...
PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cellsN Marx
Vascular Medicine and Atherosclerosis Unit, Cardiovascular Division and the Vascular Research Division, Department of Pathology, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
Circulation 99:3125-31. 1999..The present study investigated PPARalpha expression in human ECs and their regulation of vascular cell adhesion molecule-1 (VCAM-1)...
CD154 (CD40 ligand)U Schonbeck
Cardiovascular Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, 221 Longwood Ave, Boston, MA 02115, USA
Int J Biochem Cell Biol 32:687-93. 2000..Accordingly, CD40/CD154 interactions have advanced as a potential therapeutic target for these diseases, whereby two opposing strategies, interruption as well as enhancement of CD40 signaling, are explored for beneficial outcomes...
Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allograftsD A Mandelbrot
Immunology Research Division, Department of Pathology, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
J Immunol 163:3753-7. 1999..The indefinite survival of allografts into B7-1/B7-2-/- recipients further shows that the absence of B7 costimulation alone is sufficient to prevent rejection...
Lipid lowering improves endothelial functionsP Libby
Brigham and Women s Hospital and Harvard Medical School, 221 Longwood Avenue, LMRC 307, Boston, MA 02115, USA
Int J Cardiol 74:S3-S10. 2000..Continued probing of the basic mechanisms of endothelial dysfunction and its treatment may lead to new therapies that offer clinical benefits in patients with atherosclerosis, including reductions in coronary events...
Molecular biology of atherosclerosisP Libby
Department of Medicine, Brigham and Women s Hospital, Boston, MA 02115, USA
Int J Cardiol 62:S23-9. 1997..Rather than attempting a comprehensive overview, we will focus primarily on selected examples where new information sheds light on potential molecular mechanisms underlying these pathologic processes...
Dietary lipid lowering reduces tissue factor expression in rabbit atheromaM Aikawa
Vascular Medicine and Atherosclerosis Unit, Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass 02115, USA
Circulation 100:1215-22. 1999..Tissue factor (TF) overexpressed in atheroma may accelerate thrombus formation at the sites of plaque disruption. A cell surface cytokine CD40 ligand (CD40L) enhances TF expression in vitro...
Mechanical deformation promotes secretion of IL-1 alpha and IL-1 receptor antagonistR T Lee
Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
J Immunol 159:5084-8. 1997..This pathophysiologic mechanism may play a role in the anatomic localization of some inflammatory skin diseases, such as psoriasis, which occurs more commonly in locations where the dermis is subjected to repetitive stretch or trauma...
Lipid lowering reduces proteolytic and prothrombotic potential in rabbit atheromaM Aikawa
Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
Ann N Y Acad Sci 902:140-52. 2000..These results suggest potential mechanisms by which lipid lowering reduces acute coronary events in patients by decreasing proteolytic and prothrombotic activity within the atheroma...
Cystatin C deficiency in human atherosclerosis and aortic aneurysmsG P Shi
Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
J Clin Invest 104:1191-7. 1999..The findings highlight a potentially important role for imbalance between cysteine proteases and cystatin C in arterial wall remodeling and establish that cystatin C deficiency occurs in vascular disease...
Endothelial function and coronary artery diseaseS Kinlay
Cardiovascular Division, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
Curr Opin Lipidol 12:383-9. 2001..Such genetic heterogeneity may nonetheless offer new insights into the variability of endothelial function...
Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic miceJ H Qiao
Department of Medicine, Molecular Biology Institute, University of California, Los Angeles, USA
Am J Pathol 150:1687-99. 1997..The effects of the op mutation on atherogenesis may have resulted from decreased circulating monocytes, reduced tissue macrophages, or diminished arterial M-CSF...
Induction of endothelial-leukocyte interaction by interferon-gamma requires coactivation of nuclear factor-kappaBR De Caterina
Vascular Medicine Unit, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA
Arterioscler Thromb Vasc Biol 21:227-32. 2001..These findings suggest that factors that activate NF-kappaB can synergize with IFN-gamma in promoting endothelial-leukocyte interaction...
Soluble CD40L and cardiovascular risk in womenU Schonbeck
Leducq Center for Cardiovascular Research, Cardiovascular Medicine, Brigham and Women s Hospital, Boston, Massachusetts, USA
Circulation 104:2266-8. 2001..It is unknown, however, whether elevations of circulating sCD40L precede the onset of acute cardiovascular symptoms...
An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitroM Aikawa
Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
Circulation 103:276-83. 2001..Lipid lowering with HMG-CoA reductase inhibitors reduces acute coronary events...
Mechanical strain induces specific changes in the synthesis and organization of proteoglycans by vascular smooth muscle cellsR T Lee
Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, 02115, USA
J Biol Chem 276:13847-51. 2001..These data demonstrate that mechanical deformation increases specific vascular smooth muscle cell proteoglycan synthesis and aggregation, indicating a highly coordinated extracellular matrix response to biomechanical stimulation...
Macrophages and atherosclerotic plaque stabilityP Libby
Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Curr Opin Lipidol 7:330-5. 1996..We hypothesize that lipid-lowering reduces clinical events, as shown in recent trials, by stabilizing lesions in part by reversing some of the maladaptive functions of macrophages described above...
Circumferential stress and matrix metalloproteinase 1 in human coronary atherosclerosis. Implications for plaque ruptureR T Lee
Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass
Arterioscler Thromb Vasc Biol 16:1070-3. 1996..Degradation and weakening of the collagenous extracellular matrix at these critical high-stress regions may play a role in the pathogenesis of plaque rupture and acute ischemic syndromes...
Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosisM P Herman
Leducq Center for Cardiovascular Research, Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
J Clin Invest 107:1117-26. 2001..These findings establish a new, anti-inflammatory function of TFPI-2 of potential pathophysiological significance for human diseases, including atherosclerosis...
Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosisS K Clinton
Laboratory of Clinical Pharmacology, Dana Farber Cancer Institute, Boston, MA 02115
Am J Pathol 140:301-16. 1992..The local production of MCSF during atherogenesis may contribute to macrophage survival and proliferation or activate specific macrophage functions such as expression of the scavenger receptor and secretion of apo E...
Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse heartsH Nagano
Department of Surgery, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
J Clin Invest 100:550-7. 1997..Thus, development of GAD, but not parenchymal rejection, requires IFN-gamma. Reduced expression of MHC antigens and leukocyte adhesion molecules may contribute to the lack of coronary arteriopathy in hearts allografted into GKO mice...
Ligation of CD40 onvascular smooth muscle cells mediates loss of interstitial collagen via matrix metalloproteinase activityD B Horton
Leducq Center for Cardiovascular Research, Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
Ann N Y Acad Sci 947:329-36. 2001..Thus, CD40/CD40L interactions might play a key role in rendering atheromatous lesions prone to rupture...
Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromesS Sugiyama
Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, 221 Longwood Ave, Boston, MA 02115, USA
Am J Pathol 158:879-91. 2001....
Inhibition of CD40 signaling limits evolution of established atherosclerosis in miceU Schonbeck
Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, 221 Longwood Avenue, LMRC 309, Boston, MA 02115, USA
Proc Natl Acad Sci U S A 97:7458-63. 2000..This study lends further support to the importance of this specific inflammatory signaling pathway in atherosclerosis and its complications...
Host bone-marrow cells are a source of donor intimal smooth- muscle-like cells in murine aortic transplant arteriopathyK Shimizu
Leducq Center for Cardiovascular Research, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA
Nat Med 7:738-41. 2001..Thus, smooth-muscle--like cells in GAD lesions can originate from circulating bone--marrow-derived precursors...
The CD40/CD154 receptor/ligand dyadU Schonbeck
Cardiovascular Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
Cell Mol Life Sci 58:4-43. 2001....
What have we learned about the biology of atherosclerosis? The role of inflammationP Libby
Department of Medicine, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
Am J Cardiol 88:3J-6J. 2001..Studies in rabbits with diet-induced atherosclerosis have shown that reducing cholesterol consumption indeed decreases inflammation in atheroma and improves those features of plaques associated with stability...
MRI of rabbit atherosclerosis in response to dietary cholesterol loweringM V McConnell
Noninvasive Laboratory, Vascular Medicine, Atherosclerosis Unit, Brigham and Women s Hospital, Boston, MA 02115, USA
Arterioscler Thromb Vasc Biol 19:1956-9. 1999..Plaque progression was seen with maintenance of high-cholesterol diet. MRI is a promising noninvasive technology for directly imaging atherosclerosis and its response to therapeutic interventions...
Deficiency of the cysteine protease cathepsin S impairs microvessel growthG P Shi
Department of Medicine, University of California, San Francisco, USA
Circ Res 92:493-500. 2003..These results demonstrate a novel function of endothelium-derived Cat S in angiogenesis...
Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor- deficient miceT Rajavashisth
Atherosclerosis Research Center, Division of Cardiology, Department of Medicine, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
J Clin Invest 101:2702-10. 1998..These studies support the conclusion that M-CSF participates critically in fatty streak formation and progression to a complex fibrous lesion...
Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarctionA Ducharme
Cardiovascular Division, Department of Medicine, and Department of Pathology, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
J Clin Invest 106:55-62. 2000..The decrease in collagen accumulation and the enhanced expression of other MMPs suggest that MMP-9 plays a prominent role in extracellular matrix remodeling after MI...
Inflammation and atherothrombosisL Robbie
Leducq Center for Cardiovascular Research, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts 02115, USA
Ann N Y Acad Sci 947:167-79; discussion 179-80. 2001..Enhanced understanding of the processes involved in the development and progression of atherosclerosis and its complications will surely provide areas that can be targeted in the treatment of the disease...
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive proteinPaul M Ridker
Center for Cardiovascular Disease Prevention, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02215, USA
N Engl J Med 359:2195-207. 2008....
Deletion of EP4 on bone marrow-derived cells enhances inflammation and angiotensin II-induced abdominal aortic aneurysm formationEva H C Tang
Division of Cardiovascular Medicine, Brigham and Women s Hospital, Harvard Medical School, 77 Ave Louis Pasteur, Boston, MA 02115, USA
Arterioscler Thromb Vasc Biol 31:261-9. 2011..To examine whether a lack of prostaglandin E receptor 4 (EP4) on bone marrow-derived cells would increase local inflammation and enhance the formation of abdominal aortic aneurysm (AAA) in vivo...
Molecular imaging of macrophage protease activity in cardiovascular inflammation in vivoT Quillard
Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
Thromb Haemost 105:828-36. 2011..Imaging of macrophages and protease activity should provide an important adjunct to understanding pathophysiology in vivo, evaluating the effects of interventions, and ultimately aiding clinical care...
Stromelysin-1 (MMP-3) expression driven by a macrophage-specific promoter results in reduced viability in transgenic miceR P Fabunmi
Lipid Metabolism Unit, Massachusetts General Hospital, GRJ 1328, 55 Fruit Street, Boston, MA 02114, USA
Atherosclerosis 148:375-86. 2000....
Research Grants
- AtherothrombosisPeter Libby; Fiscal Year: 2005..This effort will hasten the translation of research discoveries to promote health of the heart and blood vessels at home and abroad. ..
- PATHOGENESIS OF TRANSPLANT ASSOCIATED ARTERIOSCLEROSISPeter Libby; Fiscal Year: 2002..The observations point to distinct mechanisms mediating acute vs. chronic allograft pathologies, and suggest that different therapeutic interventions will be uniquely applicable to each. ..
- Inflammatory Mechanisms of AtherosclerosisPeter Libby; Fiscal Year: 2006..5. We will explore a putative functional role of a novel prostaglandin E2 receptor EP4 interacting protein (EPRAP) in endogenous anti-inflammatory pathways. ..
- Determinants of Arterial Remodeling in AtherogenesisPeter Libby; Fiscal Year: 2007..Together, this project should help in understanding the mechanisms of extracellular matrix remodeling during atherogenesis, a key determinant of the clinical expression of this disease. ..
- Training Grant in Cardiovascular ResearchPeter Libby; Fiscal Year: 2007..In this application we propose to continue our longstanding record (documented within) or preparing a talented pool of fellows for successful academic careers. ..
- CONTROL OF GROWTH OF VASCULAR WALL CELLSPeter Libby; Fiscal Year: 1992..Delineation of such pathways will help to understand the mechanisms that modulate undesirable amplification of local inflammatory related to SMC growth...
- PATHOGENESIS OF TRANSPLANT-ASSOCIATED ARTERIOSCLEROSISPeter Libby; Fiscal Year: 1993..Finally, we will correlate results of these immunologic studies with angiographic evidence of vascular dysfunction or injury determined at the time of flood drawing in the same patients...
- CONTROL OF GROWTH OF VASCULAR WALL CELLSPeter Libby; Fiscal Year: 1993..The results of this study should help unravel mechanisms of arterial pathology, to understand normal vascular homeostasis, and to aid the rational design of therapies for prevalent vascular diseases...
- Molecular Determinants of Arterial Remodeling in AtherogenesisPeter Libby; Fiscal Year: 2010..This project should help in understanding the mechanisms of arterial remodeling during atherogenesis. These complementary studies will translate further preclinical findings into clinical preventive cardiovascular medicine. ..
